During the past decade there has been a major shift in the use of surgical bioprostheses. Consequently, due to the increasing age of the population there will be a major increase in the incidence of failure of these prostheses. While mortality associated with the re-replacement of surgical valve failures remains high, advances in transcatheter interventions have permitted the use of transcatheter valves in degenerative surgical bioprostheses. Herein is described the first use of the Symetis transfemoral ACURATEneo™ valve-in-valve procedure, together with details of the associated technical challenges. Video 1: Positioning of the TAVI prosthesis. Video 2: Valve deployment.

How to cite: Pllaha, E., Pagnotta, P., Rossi, M., & Reimers, B. (2017). Symetis TF ACURATEneo™ Valve-in-Valve: A New Indication for Another Self-Expanding TAVI Prosthesis?. The Journal of heart valve disease, 26(1), 32–36.